Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2154 Clinical and Morphological Features of Extrapulmonary Small-Cell Cancer
Introduction: Extrapulmonary Small-cell cancer (ESCC) is an extremely rare disease. Usually in the treatment of patients with ESCC approaches to the treatment of patients with small cell lung cancer (SCLC) are used.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Ivanov A, Gorbunova V, Delektorskaya V, Kuzminov A,
Keywords: small cell cancer, Extrapulmonary small cell cancer, somatostatin receptors,
Introduction: Intolerance of Octreotide is about 10 % of cases
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Gorbunova V, Orel N, Emelianova G, Kuzminov A, Markovich A,
Keywords: Octreotide, Lanreotide, intolerance, NETs,
Introduction: Aranoza (3-α-L-arabinopyranosyl-1-methyl-nitrosourea) – nitrosourea derivative, as STZ.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Gorbunova V, Orel N, Kuzminov A, Emelianova G, Odintsova A,
Keywords: aranoza, Neuroendocrine tumors, chemotherapy,
#1091 IFNα versus IFNα Plus Octreotide LAR in Treatment of NETs
Introduction: It is still unknown whether the combination of IFNα with octreotide LAR has benefit compared with IFNα alone
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Gorbunova V, Emelianova G, Orel G, Markovich A, Kuzminov A,
Keywords: IFNα, Octreotide LAR, NETs,
Introduction: Temozolomide (T) demonstrated promising activity in NETs in numerous phase 2 studies worldwide. But there is not enough data about its efficacy in the Russian population.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Gorbunova V, Markovich A, Orel N, Kuzminov A, Odintsova A,
Keywords: temozolomide, neuroendocrine tumors ,